This invention relates to spiroindoline compounds for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments comprising the administration of the compounds to animals in need of the treatments. Moreover this invention relates to pharmaceutical compositions and kits comprising the compounds.
S PIROINDOLINE COMPOUNDS FOR USE AS ANTHELMINTHI CS
申请人:Intervet International B.V.
公开号:EP2531506A1
公开(公告)日:2012-12-12
Spiroindoline compounds for use as anthelminthics
申请人:Intervet International B.V.
公开号:EP2531506B1
公开(公告)日:2014-05-14
US9598412B2
申请人:——
公开号:US9598412B2
公开(公告)日:2017-03-21
[EN] S PIROINDOLINE COMPOUNDS FOR USE AS ANTHELMINTHI CS<br/>[FR] COMPOSÉS SPIROINDOLINES DESTINÉS À ÊTRE UTILISÉS COMME AGENTS ANTHELMINTHIQUES
申请人:INTERVET INT BV
公开号:WO2011095581A1
公开(公告)日:2011-08-11
This invention relates to spiroindoline compounds for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments comprising the administration of the compounds to animals in need of the treatments. Moreover this invention relates to pharmaceutical compositions and kits comprising the compounds.